Literature DB >> 25486720

Risk factors related to cognitive functioning: a cross-national comparison of U.S. and Korean older adults.

Jiyoung Lyu, Chae Man Lee, Elizabeth Dugan.   

Abstract

The purpose of this study was to conduct a cross-national comparison of factors related to cognitive functioning in later life in a U.S. and Korean sample. The study sample was comprised of subjects from the HRS (N = 10,175) and the KLoSA (N = 3,550). Separate multivariate regression models were employed to examine the impact of socio-demographic, health, and health behaviors on cognitive functioning among older adults. Regression results showed that age, gender, education, wealth, self-rated health, ADL, IADL, stroke, and poor eyesight were significantly associated with cognitive functioning in both countries. However, depression, high blood pressure, diabetes, and drinking were significantly associated with cognition only among Americans, while marital status and poor hearing were significantly associated with cognition only among Koreans. In addition, gender-specific models suggested several socio-economic and health factors had significantly different effects by gender in both countries. Cross-national comparative research identified similar risk factors, suggesting robust associations. Unique factors related to cognitive functioning in U.S. and Korean older adults highlight the important role of societal influences on cognitive outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25486720

Source DB:  PubMed          Journal:  Int J Aging Hum Dev        ISSN: 0091-4150


  2 in total

1.  The Education of Multiple Family Members and the Life-Course Pathways to Cognitive Impairment.

Authors:  Jenjira J Yahirun; Sindhu Vasireddy; Mark D Hayward
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-08-13       Impact factor: 4.077

2.  Gender-Specific Incidence and Predictors of Cognitive Impairment among Older Koreans: Findings from a 6-Year Prospective Cohort Study.

Authors:  Jiyoung Lyu; Hae-Young Kim
Journal:  Psychiatry Investig       Date:  2016-09-30       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.